Latest Updates
-
Onam 2026: Kasavu Saree, But Make It Fashion-Forward With 7 Chic Styling Tricks -
From Biarritz Runway To Red Carpet: How Chanel’s Barefoot Heel Cap Became Fashion’s Latest Viral Controversy -
Partial Lunar Eclipse 2026: Raksha Bandhan Coincides With Rare Celestial Event, But Is It Visible In India? -
Tokyo Earthquake: 5.9-Magnitude Quake Shakes Japan, Leaves 37 Injured -
Tamil Nadu’s One-Year Maternity Leave For Third Child: Gynaecologist Explains How The Move Could Help Mothers -
Shravana Putrada Ekadashi 2026: Date, Rituals, Vrat Katha and More -
Screen Time, Sunlight and Squinting: An Eye Doctor Decodes Childhood Myopia -
Chennai Turns 387: Inside The City's Madras Day 2026 Celebrations -
Who Is Medhavi Bidhuri? Delhi Spinner Goes Viral For '6-7' Celebration In Women's DPL -
Raksha Bandhan 2026: The Forgotten Legend Of A Wife Who Tied Rakhi To Save Her Husband
More Effective Way To Treat HIV Identified
Read to know about the effective way to treat HIV.
Scientists have discovered a more effective way to treat people suffering from HIV whose bodies have built a resistance to drug 'cocktails' currently used to keep them healthy. Researchers from University of South Carolina (USC) in the US identified a novel human protein variant that can be targeted to prevent the human immunodeficiency virus from harming HIV-positive individuals.

"Most HIV drugs target the virus but the virus is not stable, it always mutates - problematic because the virus can become resistant to effective drugs," said I-Chueh Huang, assistant professor at USC. The new study focused on HIV-1, the most widespread version worldwide. HIV can be classified into R5 and X4 viruses. R5 viruses are exclusively associated with primary infection, and X4 viruses emerge in later stages of HIV diseases in half of HIV carriers.
Detection of X4 is an indication that the patient's HIV infection has progressed to a very toxic state. Researchers identified a novel variant within the previously identified family of proteins. They nicknamed it "Delta 20," an immune system protein that suppresses the most damaging HIV strains, X4, by preventing the virus from infecting cells.
This method differs from the more traditional method of targeting viruses that may eventually become resistant to specific medical therapies, researchers said. "Much more research needs to be done, but we may have identified a new approach to treating acute HIV infection," Huang said. "Our finding will not help develop a vaccine because the focus is on innate immunity rather than the virus," Huang said. "Perhaps one day scientists will create medicine that, like 'HIV cocktails,' have to be taken indefinitely.

But the new treatment may be more effective because it is harder for viruses to escape the body's defences," Huang added. The study was published in the journal Proceedings of the National Academy of Sciences.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications